Nachrichten zur AstraZeneca PLC Aktie

In der vergangenen Woche erreichte die Aktie von Astrazeneca ein neues Jahreshoch von 12.646,00 Britischen Pence und durchbrach damit den…

Die Aktie des britisch-schwdischen Pharmakonzerns Astrazeneca ist nicht zu bremsen. Zuletzt gelang dem Papier der Sprung auf ein neues Jahreshoch.…

Die Aktie des britisch-schwdischen Pharmakonzerns Astrazeneca ist nicht zu bremsen. Zuletzt gelang dem Papier der Sprung auf ein neues Jahreshoch.…

The FDA grants priority review to AstraZenecas (AZN) Tagrisso for treating patients with unresectable, stage III EGFR-mutated lung cancer. A…

…

Eli Lillys (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVies (ABBV) Skyrizi and AstraZenecas (AZN) Tagrisso.…

Plus: Annie Lamont, Robert Nelsen, Hemant Taneja and more healthtech venture capital investors on this years Forbes Midas list.…

05 June 2024 Acquisition of Fusion completed AstraZeneca today announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage…

AstraZeneca CEO Pascal Soriot discussed his companys ambitious revenue goal with CNBCs Jim Cramer.…

3 June 2024 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

AstraZeneca Plc’s lung and breast cancer drugs significantly slowed the spread of disease in two trials, potentially establishing the medicines…

…

The Global Dyspepsia Drugs Market Size was Valued at USD 9.5 Billion in 2023 and the Worldwide Dyspepsia Drugs Market…

AstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company should be able to repeat this feat over…

AstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company should be able to repeat this feat over…

NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat die Bewertung der Aktien von Astrazeneca…

NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat die Bewertung der Aktien von Astrazeneca bei einem Kursziel…

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Bewertung der Aktien von Astrazeneca bei einem Kursziel von…

The global pharmaceutical market reached a total value of US$1.6 trillion in 2023, according to Statista, up significantly from the…

…

Both businesses have road maps for the future, but one is better.…

AstraZenecas (AZN) shares decline as it fails to achieve statistically significant overall survival data in a late-stage NSCLC study on…

New York (www.aktiencheck.de) - Rating-Update: Mark Purcell, Analyst von Morgan Stanley, stuft die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN:weiterhin mit…

This announcement contains inside information 27 May 2024 Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small…

The Global Topical Wound Agents Market Size was valued at USD 1.9 Billion in 2023 and the Global Topical Wound…

Durch sein Corona-Vakzin wurde AstraZeneca einer breiten Öffentlichkeit bekannt. Der Impfstoff ist inzwischen Geschichte. Nun präsentierte Konzernchef Soriot jüngst neue…

…

AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase…

Sweden is a vital part of AstraZeneca. And the company plays a key role in Sweden and Gothenburg’s business environment.…

…

Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von AstraZeneca plc (ISIN: GB0009895292,…

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca mit einem Kursziel von 13000 Pence auf…

These are the stocks posting the largest moves midday.…

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca gab heute sein ehrgeiziges Ziel bekannt, 2030 einen Gesamtumsatz von USD 80 Mrd. zu erzielen – gegenüber…

The FTSE 100 dipped on Tuesday after investors were served an unwelcome reminder that the Federal Reserve rate cuts were…

AstraZeneca aims for $80 billion in total revenue by 2030…

AstraZeneca shares rise as pharma group unveils 2030 revenue target…

Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Pharmaceutical company AstraZeneca is planning to increase its total revenue by 75% and release 20 new medicines by 2030, including…

Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Antiandrogens Market Report: Trends, Forecast and Competitive Analysis to 2030"…

Astrazeneca CFO Aradhana Sarin discusses the companys growth plans with Guy Johnson, Kriti Gupta and Anna Edwards on Markets Today.…

CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca will durch die Einführung zahlreicher neuer Medikamente in den…

AstraZeneca PLC (LSE:AZN) aims to grow its revenue by about 75% to $80 billion by 2030, driven by the launch…

European stocks fall in Fed rate concerns; AstraZeneca lifts revenue target…

FTSE 100 falls 34 points to 8390 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets…

FTSE 100 falls 37 points to 8387 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets for…

8.07am: FTSE 100 falls out of bed The FTSE 100 has dropped 30 points to 8394 in initial trades, with all…

FTSE 100 falls 7 points to 8416 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets…

FTSE 100 falls 29 points to 8395 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets…

FTSE 100 falls 22 points to 8402 Pennon leads water companies lower AstraZeneca sets new targets for decade 8.28am: Water…